About Dr Lalchandani Labs Ltd
Dr Lalchandani Labs is engaged in the business of running laboratories for carrying out pathological investigations of various branches of bio-chemistry, hematology, histopathology, microbiology, electrophoresis, immunology, virology, cytology, and other pathological and radiological investigations
Founded
2017
CEO
Arjan Lal Chandani
Employees
0
HQ
New Delhi, New Delhi
Finished Products
1Sale of Services
₹9.26CrRaw Materials
1Raw Material Consumed
₹3.01CrAbout Dr Lalchandani Labs Ltd
Dr Lalchandani Labs is engaged in the business of running laboratories for carrying out pathological investigations of various branches of bio-chemistry, hematology, histopathology, microbiology, electrophoresis, immunology, virology, cytology, and other pathological and radiological investigations
Founded:2017
CEO:Arjan Lal Chandani
Employees:0
HQ:New Delhi, New Delhi
Finished Products
1Sale of Services
₹9.26CrRaw Materials
1Raw Material Consumed
₹3.01CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹21
52W Low
₹6
Volume20.00K
Avg VolumeN/A
Beta0.12
Dividend Yield0.00%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
112.57x
Valuation
P/B Ratio
0.48x
Valuation
EPS
₹0.07
Valuation
Dividend Yield
0.00%
Valuation
ROE
0.45%
Profitability
ROCE
0.71%
Profitability
Revenue by Segment
Contribution & growth by business line
No segment revenue data available
Geographical Revenue Split
Domestic vs international exposure
Domestic
0.0%
International
0.0%
No geographic split data available
Strategic Relations
Collaborations, joint ventures & subsidiaries
No collaborations data available.
Forensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.15x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
-4.1%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.